The effect of Panax ginseng supplementation on markers of resistance exercise-induced muscle damage: a systematic review

Morgans, Ryland; Scholten, Jule S.; Rhodes, Dave; Ceylan, Halil İ.; Ryan, Ben; Oliveira, Rafael; Clifford, Tom

http://hdl.handle.net/10400.15/4921

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
JSportsMedPhysFitness-15832_ProofinPDF_V2_2024-05-20.pdf		923.33 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

INTRODUCTION: According to the PRISMA guidelines, this systematic review of randomized controlled trials examined whether Panax gin seng supplementation reduces resistance to exercise-induced muscle damage (EIMD). EVIDENCE ACQUISITION: Web of Science, SPORTDiscus and Medline databases were searched from the 16th of December 2021 to the 18th of February 2022. Inclusion criteria were studies in humans consuming Panax ginseng that employed resistance training as the damaging muscle protocol and measured markers implicated in the etiology of EIMD (muscle damage, muscle function and muscle soreness). The PEDro risk of bias assessment tool was used to appraise the studies critically. RESULTS: Conflicting evidence was evident in markers of muscle damage, muscle function and muscle soreness. The quality assessment sug gested that all studies had some level of bias. CONCLUSIONS: From 180, six studies were included in the systematic review. The main findings suggest that Panax ginseng does not attenu ate markers of EIMD following resistance training. However, research is still preliminary. Adequately powered sample sizes and well-controlled studies are warranted to clarify Panax ginseng’s efficacy.

Keywords

exercise Panax resistance training myalgia

URI

http://hdl.handle.net/10400.15/4921

Citation

Morgans,R., J.S., Rhodes,D.,Ceylan,H.I.,Ryan,B.,Oliveira,R. & Clifford,T. (2024). The effect of Panax ginseng supplementation on markers of resistance exercise-induced muscle damage: a systematic review. The Journal of Sports Medicine and Physical Fitness,64.